SYDNEY, July 12, 2011 - Australian biotech company Clinical Genomics Pty Ltd today announced agreement with Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, to extend a strategic alliance between the two companies related to Clinical Genomics' proprietary biomarkers for colorectal cancer and precancerous colorectal cancer tumors. Under the agreement, Quest Diagnostics will make milestone payments to Clinical Genomics for the development and validation of new molecular blood tests for the early detection of colorectal cancer. Clinical Genomics has been awarded payments after successfully achieving key research and development goals. Additional terms were not disclosed.
SYDNEY, June 30, 2011 - Goodman Group (Goodman or Group) is pleased to announce the acquisition by Canada Pension Plan Investment Board (CPPIB) of the Group's 50% interest in the Hong Kong Interlink Project.
Older News
S M T W T F S
24 25 26 27 28 29 30
31 1 2 3 4 5 6
7 8 9 10 11 12 13
Copyright© 2011 The Gaea Times